SCHEMBL21369765

SCHEMBL21369765

c1ccc(-c2nc(-c3cc(-c4cc5ccccc5c5ccccc45)cc(-n4c5ccccc5c5ccccc54)c3)nc(-n3c4ccccc4c4ccccc43)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.40
KDM4E B2RXH2 3/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
ATM Q13315 3/20 0.38
MAPT P10636 4/20 0.33
MEN1 O00255 4/20 0.33
HPGD P15428 4/20 0.33
KMT2A Q03164 4/20 0.33
ALDH1A1 P00352 3/20 0.33
MPI P34949 1/20 0.33
ALOX5 P09917 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.31
LMNA P02545 2/20 0.31
NPC1 O15118 1/20 0.31
RECQL P46063 1/20 0.31
RAB9A P51151 1/20 0.31
ABCG2 Q9UNQ0 2/20 0.31
HSD17B10 Q99714 2/20 0.31
TP53 P04637 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21369807 0.96 CYP11B1 (0.42) CYP11B1KDM4EL3MBTL1ATMMAPT
SCHEMBL21370172 0.94 CYP11B1 (0.40) CYP11B1KDM4EL3MBTL1ATMMAPT
SCHEMBL21370170 0.94 CYP11B1 (0.40) CYP11B1KDM4EL3MBTL1ATMMAPT
SCHEMBL21369805 0.94 CYP11B1 (0.40) CYP11B1KDM4EL3MBTL1ATMMAPT
SCHEMBL21369899 0.93 CYP11B1 (0.35) CYP11B1KDM4EL3MBTL1ATMALOX5
SCHEMBL21369806 0.91 CYP11B1 (0.39) CYP11B1KDM4EL3MBTL1ATMMAPT
SCHEMBL21369963 0.91 CYP11B1 (0.40) CYP11B1KDM4EL3MBTL1ATMMAPT
SCHEMBL21369713 0.89 CYP11B1 (0.37) CYP11B1KDM4EL3MBTL1ATMMAPT
SCHEMBL21369905 0.89 CYP11B1 (0.37) CYP11B1KDM4EL3MBTL1ATMMAPT
SCHEMBL21369799 0.89 CYP11B1 (0.40) CYP11B1KDM4EL3MBTL1ATMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190288215-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME SOULBRAIN CO., LTD. (KR) 2019-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190288215-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 CYP11B1 37/4885KDM4E 2473/4885L3MBTL1 1787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.